D. Cirillo (Milan, Italy), C. Herzmann (Borstel, Germany)
TLR2 subfamily gene polymorphisms are associated with BCG osteitis after vaccination in newborns - a nationwide study from Finland
K. Nuolivirta, J. Vuononvirta, L. Kröger, H. Huhtala, M. Korppi (Tampere, Seinäjoki, Turku, Kuopio, Finland)
|   |
Hypoxia signaling modulates neutrophil nitric oxide in a zebrafish tuberculosis model
P. Elks, M. van der Vaart, F. van Eeden, H. Spaink, S. Walmsley, A. Meijer, S. Renshaw (Sheffield, United Kingdom; Leiden, Netherlands)
| |
Diagnosis of abdominal tuberculosis in East London, UK
J. L. S. Ooi, F. W. D. Tai, S. Wong, M. A. Thaha, J. L. Potter, V. L. C. White, H. Kunst (London, United Kingdom)
| |
Cholecalciferol supplementation in patients taking anti tuberculosis treatment
S. K. Chityala (TadepalliGudem, India)
| |
Evaluating aerosol administration of a candidate TB vaccine MVA85A
Z. R. Manjaly Thomas, I. Satti, S. Harris, J. Meyer, S. Sheehan, H. Bettinson, H. McShane (Oxford, London, United Kingdom)
| |
Treatment for latent tuberculosis infection in migrants carries a low risk of hepatotoxicity
V. Macavei, C. Hyams, J. Ullah, T. O'Shaughnessy, V. White, J. Potter, N. Jayasekera, H. Kunst (London, United Kingdom)
| |
MDR-TB treatment outcomes in HIV positive patients
A. Skrahina, A. Khaliaukin, H. Hurevich, L. Zhylevich, V. Rusovich, E. Belilovski, A. Shyrayeu, M. Dara (Minsk, Gomel, Belarus; Moscow, Russian Federation; Copenhagen, Denmark)
| |
Use of an ELISPOT interferon-gamma release assay for screening of end-stage renal failure contacts in haemodialysis centres
C. Chee, L. Lim, C. K. Koh, K. W. KhinMar, S. H. Gan, Y. T. Wang (Singapore, Singapore)
| |
Should patients with active tuberculosis be routinely screened for chronic viral hepatitis?
J. L. Potter, Z. O. Babiker, H. Kunst, G. R. Foster, V. L. C. White (London, United Kingdom)
| |
Can we predict which lymph node tuberculosis has higher risk of relapsing?
J. Costa, A. Carvalho, R. Duarte (Gaia, Porto, Portugal)
| |
Utility of Th1-cell immune responses in differentiating active tuberculosis from latent tuberculosis infection
L. Zhang, Y. Song, Y. Zhang, Q. Li, M. Gao, X. Shi, Y. Zhang, Y. Zhang, A. Lalvani, X. Liu (Beijing, China; London, United Kingdom)
| |
Rapid detection of mycobacterial growth in in vitro cultures by VOC analysis
R. Purkhart, G. Becher, P. Reinhold, H. Köhler (Lichtenau, Bernau, Jena, Germany)
| |
Dynamic changes of Th1-cell immune response to ESAT-6 and CFP-10 during anti-tuberculosis treatment
L. Zhang, Q. Li, Y. Zhang, Y. Song, M. Gao, X. Shi, Y. Zhang, Y. Zhang, A. Lalvani, X. Liu (Beijing, China; London, United Kingdom)
| |
Multiplexed cytokine and chemokine profiling in patients with latent tuberculosis infection: Treatment effect
P. Escalante, T. Peikert, V. P. Van Keulen, C. L. Erskine, M. D. Behrens, L. A. Schenck, A. H. Limper (Rochester, United States Of America)
| |